These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 19239833)

  • 21. The use of the synthetic enhancer substances (-)-deprenyl and (-)-BPAP in major depression.
    Gaszner P; Miklya I
    Neuropsychopharmacol Hung; 2004 Dec; 6(4):210-20. PubMed ID: 15825677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder.
    Leuchter AF; Cook IA; Gilmer WS; Marangell LB; Burgoyne KS; Howland RH; Trivedi MH; Zisook S; Jain R; Fava M; Iosifescu D; Greenwald S
    Psychiatry Res; 2009 Sep; 169(2):132-8. PubMed ID: 19709754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the efficacy of desvenlafaxine for improving functioning and well-being outcome measures in patients with major depressive disorder: a pooled analysis of 9 double-blind, placebo-controlled, 8-week clinical trials.
    Soares CN; Kornstein SG; Thase ME; Jiang Q; Guico-Pabia CJ
    J Clin Psychiatry; 2009 Oct; 70(10):1365-71. PubMed ID: 19906341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of neuropsychiatric symptoms associated with euthyroid Hashimoto thyroiditis with antidepressants: a case report.
    Andreou C; Bozikas VP; Lagoudis A; Paspali D; Fokas K
    Gen Hosp Psychiatry; 2009; 31(2):199-200. PubMed ID: 19269547
    [No Abstract]   [Full Text] [Related]  

  • 25. Transdermal permeation of selegiline from hydrogel-membrane drug delivery systems.
    Fang JY; Hung CF; Chi CH; Chen CC
    Int J Pharm; 2009 Oct; 380(1-2):33-9. PubMed ID: 19563870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of antipsychotics in the treatment of major depressive disorder in the U.S. Department of Veterans Affairs.
    Mohamed S; Leslie DL; Rosenheck RA
    J Clin Psychiatry; 2009 Jun; 70(6):906-12. PubMed ID: 19422760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identifying difficult-to-treat depression: differential diagnosis, subtypes, and comorbidities.
    Gaynes BN
    J Clin Psychiatry; 2009; 70 Suppl 6():10-5. PubMed ID: 19922739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First depression patch approved.
    FDA Consum; 2006; 40(3):4. PubMed ID: 16909484
    [No Abstract]   [Full Text] [Related]  

  • 29. Initial treatment approaches for patients with major depressive disorder.
    Papakostas GI
    J Clin Psychiatry; 2009 Jun; 70(6):e18. PubMed ID: 19573474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychopharmacology: much the same.
    Grgas M; Ehret MJ
    Conn Med; 2009 May; 73(5):281-4. PubMed ID: 19441763
    [No Abstract]   [Full Text] [Related]  

  • 31. Treating partial responders to antidepressant treatment.
    Trivedi MH
    J Clin Psychiatry; 2009 Sep; 70(9):e31. PubMed ID: 19818237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and treatment of a major depressive episode.
    Thase ME
    J Clin Psychiatry; 2009 Oct; 70(10):e37. PubMed ID: 19906336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zelrix: a novel transdermal formulation of sumatriptan.
    Pierce M; Marbury T; O'Neill C; Siegel S; Du W; Sebree T
    Headache; 2009 Jun; 49(6):817-25. PubMed ID: 19438727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of blonanserin in combination therapy for treatment-resistant depression.
    Kumagai R; Ichimiya Y
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):593-4. PubMed ID: 19659567
    [No Abstract]   [Full Text] [Related]  

  • 35. Selegiline transdermal system: use pattern and adherence in patients with major depressive disorder.
    Sclar DA; Cohen LJ; Portland KB
    Prim Care Companion CNS Disord; 2013; 15(1):. PubMed ID: 23724341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of patients with major depressive disorder after serious suicide attempt.
    Suominen K; Haukka J; Valtonen HM; Lönnqvist J
    J Clin Psychiatry; 2009 Oct; 70(10):1372-8. PubMed ID: 19906342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging drugs for major depressive disorder.
    Kennedy SH; Rizvi SJ
    Expert Opin Emerg Drugs; 2009 Sep; 14(3):439-53. PubMed ID: 19637989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diurnal mood variation in outpatients with major depressive disorder.
    Morris DW; Trivedi MH; Fava M; Wisniewski SR; Balasubramani GK; Khan AY; Jain S; Rush AJ
    Depress Anxiety; 2009; 26(9):851-63. PubMed ID: 19306304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New onset somnambulism associated with different dosage of mirtazapine: a case report.
    Yeh YW; Chen CH; Feng HM; Wang SC; Kuo SC; Chen CK
    Clin Neuropharmacol; 2009; 32(4):232-3. PubMed ID: 19644232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The modern pharmacopoeia: a return to depressive realism?
    Goldberg JF
    Bipolar Disord; 2008 Dec; 10(8):969-72. PubMed ID: 19594511
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.